📊Executive Summary

Synopex is seeing positive results from its investments in electric vehicle (EV) flexible printed circuit boards (FPCBs), semiconductors, and artificial kidney technologies. The company plans to begin mass production of EV FPCB products in the first half of next year, having secured a European automaker as a customer. Additionally, Synopex is moving towards commercialization of its semiconductor filters, with the installation of a 10-nanometer-class chemical filter in a new production facility. The company is also working on localization of ultrapure water technology for semiconductor manufacturing. These developments indicate a strategic shift towards automotive and semiconductor markets, which could impact procurement strategies in these sectors....